But heres the problem: GLP-1s dont address the root causes that led to insulin resistance, inflammation, and hormone imbalance in the first place
In people with a history of restrictive eating disorders like anorexia nervosa, that appetite suppression can reinforce dangerous behaviors
Additionally, studies have indicated that GLP-1RAs may directly stimulate acinar cells, leading to increased pancreatic enzyme levels and a potential pathway for the development of pancreatitis 14,15
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
In the UK and Ireland, both peptides can be legally purchased for research use through verified suppliers
[15] Bitter compounds activate T2Rs that release CCK during digestion